Search For "zydus"
It would be disaster if COVID-19 vaccines administered to children without
Updated : 4 years, 10 months ago IST
New Delhi [India], July 16 (ANI): The Delhi High Court on Friday said that if COVID-19 vaccines are administered to children without proper research then it may be a disaster while objecting to the submission of the petitioner seeking research on vaccines for children in a time-bound mann
Read More
Zydus Cadila's COVID vaccines for children may be available in near future
Updated : 4 years, 10 months ago IST
New Delhi [India], July 16 (ANI): Pharmaceutical major Zydus Cadila's COVID-19 vaccine may be available in the near future for children in the age group of 12 to 18 years, the Centre in an affidavit told the Delhi High Court on Friday.
Read More
Emergency approval for Zydus Cadila to take few more days, say sources
Updated : 4 years, 10 months ago IST
New Delhi [India], July 12 (ANI): India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its COVID-19 vaccine ZyCoV-D in a few more days, sources told ANI.
Read More
NASSCOM CoE launches Healthcare Innovation Challenge 2.0 to focus on digit
Updated : 4 years, 10 months ago IST
New Delhi [India], July 10 (ANI/NewsVoir): After the success of the first edition of Healthcare Innovation Challenge (HIC), a unique initiative by the NASSCOM Centre of Excellence CoE - IoT & AI - a MeitY initiative with State Govt., today launched Healthcare Innovation Challenge (HIC) 2
Read More
Union Minister Mansukh Mandaviya visits COVID-19 vaccine manufacturing fac
Updated : 4 years, 10 months ago IST
Ahmedabad (Gujarat) [India], July 4 (ANI): Union Minister of State for Chemicals and Fertilisers Mansukh Mandaviya on Sunday visited the COVID-19 vaccine manufacturing facilities of Zydus Cadila and Hester Biosciences in Gujarat.
Read More
Decision on Zydus Cov-D vaccine expected soon: Dr VK Paul
Updated : 4 years, 10 months ago IST
New Delhi [India], July 2 (ANI): A decision on the approval of Zydus Cadila's COVID-19 vaccine Zydus Cov-D is expected soon, Dr VK Paul, Member (Health) of the NITI Aayog said on Friday, adding that the data and evaluation would determine the outcome.
Read More
Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims to produce 1
Updated : 4 years, 10 months ago IST
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
Read More
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccin
Updated : 4 years, 10 months ago IST
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
Read More
Zydus Cadila COVID-19 vaccine for children above 12 yrs expected by August
Updated : 4 years, 10 months ago IST
New Delhi [India], June 27 (ANI): Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical Advisory Group on Immunisation (NTAGI).
Read More
Zydus Cadila likely to seek emergency authorisation for ZyCoV-D COVID-19 v
Updated : 4 years, 11 months ago IST
New Delhi [India], June 18 (ANI): Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.
Read More
Zydus Cadila, first Indian Company gets recommendation for clinical trials
Updated : 4 years, 11 months ago IST
New Delhi [India], June 4 (ANI): The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of COVID-19 has been recommended to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drug
Read More
Zydus Cadila Q4 net profit up 73 pc at Rs 679 crore
Updated : 4 years, 12 months ago IST
Ahmedabad (Gujarat) [India], May 27 (ANI): Pharmaceutical major Zydus Cadila said on Thursday its net profit jumped 73 per cent year-on-year to Rs 679 crore during the quarter ended March.
Read More